Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study

NCT: NCT04130737 · COMPLETED

NCT IDNCT04130737
StatusCOMPLETED
Start Date2018-08-13
Completion2025-02-14
SponsorEndologix (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of the TORUS 2 IDE Clinical Study is to evaluate the safety and effectiveness of the TORUS Stent Graft System in the treatment of obstructive atherosclerotic lesions of the native SFA or the superficial femoral and/or proximal popliteal arteries.

Frequently Asked Questions

What is The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study?

The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study is a clinical trial registered under NCT04130737. Current status: COMPLETED.

What is the status of NCT04130737?

The current status of NCT04130737 (The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study) is: COMPLETED.

When did The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study start?

The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study started on 2018-08-13.

Related Devices

PMA P220021Stent graft, bypass, superficial femoral arteryEndologix, LLC PMA P040002SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTEndologix, LLC PMA P120006SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTEndologix, LLC PMA P070014STENT, SUPERFICIAL FEMORAL ARTERYBard Peripheral Vascular, Inc. PMA P110023STENT, SUPERFICIAL FEMORAL ARTERYMedtronic Vascular, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑